While Dana-Farber has been leading the way for 75 years, during the last 50 years our renowned clinical fellowship program has attracted the brightest early career physicians, researchers, and nurse-scientists to Dana-Farber in their pursuit of specialized training opportunities in cancer medicine. This panel features some of the successful graduates from this program who have gone on to lead influential careers in oncology throughout the country. They discuss the legacy of Dana-Farber’s fellowship program and its impact on future oncologists.
MODERATED BY: Robert J. Mayer, MD Faculty Vice President for Academic Affairs, Dana-Farber Cancer Institute | Stephen B. Kay Family Professor of Medicine, Harvard Medical School
FEATURING:
Levi Garraway, MD, PhD Executive Vice President, Head of Global Product Development | Chief Medical Officer, Roche and Genentech
Ann LaCasce, MD, MMSc Director, Dana-Farber/Mass General Brigham Fellowship Program in Hematology/Oncology Chair at Dana-Farber
Thomas J. Lynch Jr., MD President and Director, Fred Hutchinson Cancer Center
Nadine Jackson McCleary, MD, MPH Medical Director, Patient Reported Data Program | Medical Oncologist, Gastrointestinal Cancer Center |Leader, Inclusion, Diversity, & Equity Clinical Trial Access Committee, Dana-Farber Cancer Institute
Norman E. “Ned” Sharpless, MD Former Director, National Cancer Institute

свернуть